Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Some people may temporarily lose more hair in certain areas after a hair transplant.

The Nd:YAG laser is a successful and safe way to treat ingrown and pincer nails.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Hair loss in black women needs more research, early intervention, and community education.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Hydroxychloroquine can help treat certain types of hair loss.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.